These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27023371)

  • 1. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
    Smith J; Thompson S; Lee K
    SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From adversary to target market: the ACT-UP boycott of Philip Morris.
    Offen N; Smith EA; Malone RE
    Tob Control; 2003 Jun; 12(2):203-7. PubMed ID: 12773732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corporate philanthropy, political influence, and health policy.
    Fooks GJ; Gilmore AB
    PLoS One; 2013; 8(11):e80864. PubMed ID: 24312249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atlas network: a "strategic ally" of the tobacco industry.
    Smith J; Thompson S; Lee K
    Int J Health Plann Manage; 2017 Oct; 32(4):433-448. PubMed ID: 27125556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unhealthy partnerships: the tobacco industry and African American and Latino labor organizations.
    Raebeck A; Campbell R; Balbach E
    J Immigr Minor Health; 2010 Apr; 12(2):228-33. PubMed ID: 19579065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fag Lady, revisited: Margaret Thatcher's efforts on behalf of the tobacco industry.
    Petticrew M; Krishnaratne S
    Public Health; 2014 Oct; 128(10):904-10. PubMed ID: 25239649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
    Agonnoude MT; Mesenge C
    Sante; 2010; 20(2):116-24. PubMed ID: 20685643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.
    Schick SF; Glantz SA
    Tob Control; 2007 Jun; 16(3):157-64. PubMed ID: 17565125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow the money: how the billions of dollars that flow from smokers in poor nations to companies in rich nations greatly exceed funding for global tobacco control and what might be done about it.
    Callard C
    Tob Control; 2010 Aug; 19(4):285-90. PubMed ID: 20610436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to undermine tobacco control: tobacco industry "youth smoking prevention" programs to undermine meaningful tobacco control in Latin America.
    Sebrié EM; Glantz SA
    Am J Public Health; 2007 Aug; 97(8):1357-67. PubMed ID: 17600260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
    Crosbie E; Bialous S; Glantz SA
    Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].
    Bekelynck A
    Bull Soc Pathol Exot; 2015 Feb; 108(1):57-62. PubMed ID: 25407333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco industry sponsorship of community-based public health initiatives: why AIDS and domestic violence organizations accept or refuse funds.
    Stone M; Siegel MB
    J Public Health Manag Pract; 2004; 10(6):511-7. PubMed ID: 15643374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardised tobacco packaging: a health policy case study of corporate conflict expansion and adaptation.
    Hatchard JL; Fooks GJ; Gilmore AB
    BMJ Open; 2016 Oct; 6(10):e012634. PubMed ID: 27855104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Project Cerberus: tobacco industry strategy to create an alternative to the Framework Convention on Tobacco Control.
    Mamudu HM; Hammond R; Glantz SA
    Am J Public Health; 2008 Sep; 98(9):1630-42. PubMed ID: 18633079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health.
    Burch T; Wander N; Collin J
    Tob Control; 2010 Dec; 19(6):e1-9. PubMed ID: 21088061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.